PharmAthene Inc., an Annapolis pharmaceutical company, recently scored a victory in Delaware’s highest court in a dispute with rival Siga Technologies Inc. The Delaware Supreme Court affirmed the Delaware Court of Chancery’s decision to award PharmAthene lump sum expectation damages ...

Tagged with: delaware pharmathene inc

PharmAthene Inc., an Annapolis-based company that develops biodefense products, is changing its chief executive officer and plans to cut its 11-person staff by two-thirds, the firm announced this week. John M. Gill, a director of PharmAthene for nine years, will ...

Tagged with: pharmathene inc

(Bloomberg) Siga Technologies Inc., the maker of a smallpox drug to counter biological attacks, was told to pay $113 million to Annapolis-based PharmAthene Inc. in a dispute over the medicine that drove Siga to seek bankruptcy protection last year. PharmAthene ...

Tagged with: pharmathene inc

PharmAthene Inc., an Annapolis-based biodefense company developing medical countermeasures against biological and chemical threats, announced Monday it has called off its planned merger with Seattle-based Theraclone Sciences Inc., a privately held developer of targeted antibody drugs.

Tagged with: breaking news Business maryland merger pharmathene inc

PharmAthene Inc., of Annapolis, a biodefense company developing medical countermeasures against biological and chemical threats, announced that the U.S. Food and Drug Administration has lifted a nearly-10-month hold placed on a proposed Phase II study of SparVax, allowing a clinical trial of the next-generation anthrax vaccine to proceed.

Tagged with: Annapolis biodefense Business FDA maryland pharmathene inc u.s. food and drug administration

Annapolis-based PharmAthene Inc. may be entitled to at least $100 million in damages after the Delaware Supreme Court held that Siga Technologies Inc. acted in bad faith in backing out of a proposed licensing agreement for its smallpox treatment medication to be used in response to a biochemical attack.

Tagged with: biodefense delaware supreme court Law lawsuit legal news pharmathene inc

PharmAthene Inc., of Annapolis, a biodefense company developing medical countermeasures against biological and chemical threats, announced that the U.S. Army Medical Research Institute for Chemical Defense has completed initial in vitro testing of the company's recombinant butyrylcholinesterase (rBChE) bioscavenger.

Tagged with: biotechnology pharmathene inc

PharmAthene Inc., of Annapolis, which is developing medical countermeasures to chemical and biological warfare agents, saw its net loss grow despite an increase in revenue during the 12-month period of 2012, compared to the prior year. PharmAthene reported a net ...

Tagged with: Annapolis Business pharmathene inc revenue

ANNAPOLIS — PharmAthene Inc. of Annapolis, a company developing medical defenses against biological and chemical threats, said it has been awarded a $5.7 million, 18-month contract by the U.S. Department of Defense to continue development of a counter-measure to ward ...

Tagged with: Annapolis chemical pharmathene inc poisoning treatment u.s. department of defense